In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid β-Glucosidase in Gaucher Disease Mouse Models

Ying Sun, Benjamin Liou, Brian Quinn et al. · 2009

Read In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid β-Glucosidase in Gaucher Disease Mouse Models by Ying Sun, Benjamin Liou, Brian Quinn et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007320.txt.

Description

Ying Sun, Benjamin Liou, Brian Quinn, and colleagues tested calcium channel drugs in Gaucher disease mouse models in 2009. Gaucher disease is a lysosomal storage disease. Mutations in an enzyme called acid beta-glucosidase cause defective breakdown and buildup of its target lipids inside cells over time.

Two L-type calcium channel blockers, verapamil and diltiazem, had been reported to affect that enzyme's environment. The authors evaluate the drugs in living animals and in tissue outside the body. Their PLOS ONE study tests whether common heart drugs could aid the faulty enzyme in Gaucher disease.

Catalog record

CREATORYing Sun, Benjamin Liou, Brian Quinn et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007320

Browse the full library · About the Tower of Babel